PPH Holdings
VanEck Pharmaceutical ETF
1W: -2.6%
1M: -6.5%
3M: -1.7%
YTD: +4.2%
1Y: +14.6%
3Y: +41.1%
5Y: +59.3%
$108.06
-0.08 (-0.07%)
Weekly Expected Move ±2.3%
$103
$106
$108
$111
$113
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$939M
Holdings25
Top 10 Wt71.3%
Beta0.41
% Profitable70%
Coverage100%
Portfolio Valuation
P/E18.0
P/B1.5
P/S1.7
EV/EBITDA13.4
P/FCF11.4
PEG1.07
Profitability & Returns
Gross Margin61.0%
Net Margin9.3%
ROE8.8%
ROA3.9%
ROIC6.8%
Div Yield2.49%
Leverage & Liquidity
Debt/Equity0.72
Debt/Assets0.32
Net Debt/EBITDA2.5x
Interest Cov3.8x
Current Ratio1.11
Quick Ratio0.68
Growth (YoY)
Revenue+15.5%
Net Income+31.5%
EPS+37.1%
FCF+56.9%
EBITDA+26.2%
Rev CAGR 3Y+13.6%
Quality Scores
Piotroski F6.8
Altman Z4.97
IS Quality71.8
IS Overall61.8
IS Value42.0
Median P/E21.3
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 25 | 99.6% | 27.2 |
| Other | 2 | 0.4% | — |
Smart Money Overlap
3 holdings with signals
Showing 27 of 27 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 20.86% | $216.4M | 182,670 | 38.2 | $1.1T | Healthcare |
| 2 | Merck & Co Inc | MRK | 13.47% | $139.8M | 936,245 | 114.5 | $356.4B | Healthcare |
| 3 | Novo Nordisk A/S | NVO | 5.57% | $57.8M | 1,508,849 | 9.5 | $165.7B | Healthcare |
| 4 | Pfizer Inc | PFE | 5.12% | $53.1M | 1,848,080 | 36.7 | $158.4B | Healthcare |
| 5 | Bristol-Myers Squibb Co | BMY | 4.83% | $50.1M | 797,075 | 13.5 | $124.9B | Healthcare |
| 6 | Teva Pharmaceutical Industries Ltd | TEVA | 4.70% | $48.8M | 1,225,894 | 63.2 | $46.0B | Healthcare |
| 7 | Gsk Plc | GSK | 4.52% | $46.9M | 950,149 | 14.8 | $94.2B | Healthcare |
| 8 | Mckesson Corp | MCK | 4.32% | $44.8M | 51,822 | 24.0 | $105.6B | Healthcare |
| 9 | Cencora Inc | COR | 4.24% | $44.0M | 142,909 | 22.9 | $60.1B | Healthcare |
| 10 | Haleon Plc | HLN | 3.66% | $38.0M | 4,188,649 | 18.1 | $38.8B | Healthcare |
| 11 | Novartis Ag | NVS | 3.63% | $37.7M | 258,414 | 21.3 | $268.0B | Healthcare |
| 12 | Abbvie Inc | ABBV | 3.59% | $37.3M | 141,591 | 74.0 | $464.3B | Healthcare |
| 13 | Astrazeneca Plc | AZN | 3.58% | $37.2M | 226,373 | 23.4 | $243.3B | Healthcare |
| 14 | Johnson & Johnson | JNJ | 3.43% | $35.6M | 133,019 | 29.6 | $617.0B | Healthcare |
| 15 | Sanofi Sa/France | SNY | 3.26% | $33.8M | 829,093 | 21.7 | $95.9B | Healthcare |
| 16 | Takeda Pharmaceutical Co Ltd | TAK | 2.72% | $28.2M | 1,522,522 | 49.4 | $56.8B | Healthcare |
| 17 | Zoetis Inc | ZTS | 2.45% | $25.4M | 361,497 | 11.5 | $29.2B | Healthcare |
| 18 | Viatris Inc | VTRS | 1.51% | $15.7M | 864,903 | -48.9 | $20.5B | Healthcare |
| 19 | Jazz Pharmaceuticals Plc | JAZZ | 1.30% | $13.5M | 58,227 | 15.5 | $14.8B | Healthcare |
| 20 | Corcept Therapeutics Inc | CORT | 0.75% | $7.8M | 68,234 | 223.5 | $12.6B | Healthcare |
| 21 | Axsome Therapeutics Inc | AXSM | 0.73% | $7.6M | 40,602 | -47.8 | $9.2B | Healthcare |
| 22 | Elanco Animal Health Inc | ELAN | 0.49% | $5.1M | 226,837 | -54.0 | $11.1B | Healthcare |
| 23 | Definium Therapeutics Inc | DFTX | 0.48% | $5.0M | 130,940 | -10.9 | $5.0B | Healthcare |
| 24 | Organon & Co | OGN | 0.29% | $3.0M | 215,198 | 17.4 | $3.6B | Healthcare |
| 25 | Other/Cash Cash | — | 0.25% | $2.6M | — | — | — | — |
| 26 | -USD CASH- Cash | — | 0.12% | $1.2M | 1,240,987 | — | — | — |
| 27 | Perrigo Co Plc | PRGO | 0.11% | $1.1M | 73,760 | -1.1 | $2.0B | Healthcare |